Sinequa announced the general availability of Sinequa ES Version 10. Powered by Machine Learning capabilities at its core, this ground breaking version helps deliver deep analytics of contents and user behavior, offering information with continually improving relevance to users in their work environments.
The presentation below by Derek Kane provides an overview of clustering techniques, including K-Means, Hierarchical Clustering, and Gaussian Mixed Models.
In this contributed article, Kevin Lester, Vice President of Engineering, Search and Discovery at Shutterstock discusses why machine learning offers new frontiers to marketers.
Artificial Intelligence and machine learning changes everything. Join the insideBIGDATA team at the GPU Technology Conference which will cover almost every aspect of it. Deep learning or machine learning couples the parallel processing capabilities of GPUs with the vast quantities of data unleashed by the internet — has unlocked a new generation of artificial intelligence applications. Image classification, video analytics, speech recognition, natural language processing — these are just the start.
Arterys Inc., a privately-held company dedicated to deep learning medical imaging technology, continues to advance improved imaging capabilities bringing artificial intelligence called deep learning to the healthcare field, beginning with the heart.
A recent query using Google Trends shows an interesting level of interest in machine learning over time (see figure below). There was an emergence in hype around the 2005 time-frame and led to a cooling off period, but once big data started heating up around 2010, the upward swing in interest continues until today.
As the primary facilitator of data science and big data, machine learning has garnered much interest by a broad range of industries as a way to increase value of enterprise data assets. In this article series we’ll examine the principles underlying machine learning based on the R statistical environment.
The IP & Science Business of Thomson Reuters has announced a strategic initiative with NuMedii. The companies will leverage high-quality data, knowledge and predictive technologies to identify therapeutic candidates with the greatest probability for clinical success.